NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis
Advanced SearchBrowse by AnalyteBrowse by Pre-analytical FactorSearch SOPsSOP Compendiums

Myeloperoxidase assay   Add to my SOP compendium

BRD ID: 2,028

Source: TCP Project Tier: SOP Number of times downloaded: 542

Description

This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical Center (BMC) to quantify levels of myeloperoxidase (MPO) in plasma by ELISA as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://cssi.cancer.gov/cancer-thrombosis).

Documents for Download

BARC PRO 019 Myeloperoxidase.pdf [Size: 4952 KB]
Biospecimens
  • Fluid - Plasma
Diagnoses
  • Normal
  • Neoplastic - Carcinoma
Topics
  • Biospecimen Processing
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • New Articles on the GTEx Project are Now FREELY Available!
  • Just Published!
  • April 24, 2024: Biobanking for Precision Medicine Seminar
    • More...